Your browser doesn't support javascript.
loading
Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial (MIRAD trial).
Johansen, Marie L; Schou, Morten; Rossignol, Patrick; Holm, Maria R; Rasmussen, Jon; Brandt, Niels; Frandsen, Mikkel; Chabanova, Elizaveta; Dela, Flemming; Faber, Jens; Kistorp, Caroline.
Afiliação
  • Johansen ML; Department of Endocrinology-Internal Medicine, Copenhagen University Hospital, Herlev-Gentofte Hospital, Copenhagen, Denmark.
  • Schou M; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Rossignol P; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Holm MR; Department of Cardiology, Copenhagen University Hospital, Herlev-Gentofte Hospital, Copenhagen, Denmark.
  • Rasmussen J; Université de Lorraine, Inserm CIC Plurithémathique 1433, UMRS 1116 Inserm, CHRU Nancy, and FCRIN INI-CRCT, Nancy, France.
  • Brandt N; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Frandsen M; Department of Endocrinology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Chabanova E; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Dela F; Department of Endocrinology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Faber J; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Kistorp C; Department of Radiology, Copenhagen University Hospital, Herlev-Gentofte Hospital, Copenhagen, Denmark.
Diabetes Obes Metab ; 21(10): 2305-2314, 2019 10.
Article em En | MEDLINE | ID: mdl-31183945

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Antagonistas de Receptores de Mineralocorticoides / Fígado Gorduroso / Eplerenona / Fígado Tipo de estudo: Clinical_trials Idioma: En Revista: Diabetes Obes Metab Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Antagonistas de Receptores de Mineralocorticoides / Fígado Gorduroso / Eplerenona / Fígado Tipo de estudo: Clinical_trials Idioma: En Revista: Diabetes Obes Metab Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Dinamarca